As a board-certified urogynecologist specialising in Female Pelvic Medicine and Reconstructive Surgery, Guerette has had a close view of that evolution.
He now performs more than 600 reconstructive pelvic surgeries each year and has also worked in clinical research, medical technology development, academic medicine, and surgical leadership. Additionally, he has been elected TOP DOC for 16 consecutive years, an award granted through selection by his peers.
Dr. Nathan Guerette‘s experience has shaped the way he evaluates new ideas. For Guerette, innovation is most useful when it solves a real clinical problem, improves patient care, or gives physicians better options in complex cases.
In this interview, he discusses how his approach has changed over time, what he looks for in new medical technology, and why experience often matters most when deciding which advances are actually worth using.
Dr. Nathan Guerette on Experience, Innovation and Better Decision-Making
After performing such a high volume of reconstructive pelvic surgery, what have you learned that training alone cannot teach?
Training gives you the foundation, but experience teaches you how much variation exists between patients. You can learn the anatomy, techniques, and treatment options in a structured way, but once you have treated a large number of people, you begin to see patterns that are much harder to understand from a textbook.
You also learn that the same diagnosis does not always require the same answer. One patient may prioritise recovery time, while another may be more focused on durability, function, or a particular symptom. Experience helps you recognise those differences earlier and think about treatment in a more individual way.
Has high surgical volume changed the way you approach difficult cases?
It has made me more careful about assuming that a familiar problem will behave in a familiar way. When you have seen many variations of the same condition, you become more aware of the details that can change the plan.
That does not mean making things more complicated than they need to be. In many cases, experience actually helps simplify the decision because you have a better sense of what matters and what does not. The goal is to recognise the variables that are likely to affect the outcome and focus on those.
You work with new medical technologies as both a physician and consultant. What makes an innovation genuinely useful?
A useful innovation should solve a real problem. It should improve something meaningful, whether that is precision, recovery, safety, access, or the quality of the result.
Technology can be impressive without being especially helpful, and that distinction matters. When I look at a new device or treatment, I am interested in what clinical problem it addresses and whether that problem actually matters to patients and physicians in day-to-day practice.
How does your surgical experience influence the advice you give biomedical companies?
Practising physicians see where existing tools work well and where they create frustration. That perspective can be useful during development because a product may look good in theory but still be difficult to use in a real clinical setting.
My role is often to bring that practical view into the conversation. You can identify where a design may not fit the way a procedure is actually performed or where a small change could make something more useful. The best development process usually involves listening closely to the people who will eventually use the technology.
What role does clinical research play in deciding whether a new treatment belongs in patient care?
Research gives us a way to evaluate new ideas in a structured and responsible way. Our practice has participated in clinical studies, including FDA-level research, because new treatments need more than enthusiasm behind them.
You want evidence that something does what it is supposed to do and that it offers a meaningful benefit. Research also helps identify limitations, which is just as important as identifying advantages. Good medicine depends on knowing both.
Do more treatment options always lead to better care?
Not necessarily. Having more options is useful only if you understand when each one makes sense.
Sometimes the best treatment is a newer approach, and sometimes it is a method that has been used successfully for years. The important part is matching the treatment to the patient rather than choosing something simply because it is new or technically advanced.
How have patients changed over the course of your career?
Patients today often arrive with much more information than they did years ago. They may have researched procedures, devices, or treatment options before the first appointment, which can be helpful but can also create confusion when information online lacks context.
That makes communication more important. Part of the physician’s job is helping patients understand what applies to their situation and what does not. Information is useful, but individual medical judgement still matters.
What continues to interest you most about the field?
There is still a great deal of room for improvement in women’s pelvic health, and that keeps the work interesting. Better technology, better research, and better surgical techniques all have a role, but I am most interested in how those things translate into better outcomes for individual patients.
After years in the field, I think experience teaches you to be both open to change and cautious about change for its own sake. Innovation matters, but good judgement is still what connects innovation to better care.
